CHI3L1 and central nervous system cancer: In conclusion, EMP3 and CHI3L1 can be used as prognostic indicators in low-grade gliomas, and the OS and DFS of patients with low EMP3 and CHI3L1 are significantly better than those of patients with high EMP3 and CHI3L1.